Information Provided By:
Fly News Breaks for June 19, 2017
CLVS, TSRO
Jun 19, 2017 | 11:56 EDT
Cowen analyst Boris Peaker reduced Tesaro's (TSRO) price target to $125 from $145 following Clovis' report this morning that rucaparib's pivotal ARIEL3 study met its PFS endpoint. The analyst said that all three leading PARPs are largely undifferentiated and trimmed niraparib peak rates across all subgroups. The analyst rates Tesaro shares a Market Perform.
News For TSRO;CLVS From the Last 2 Days
There are no results for your query TSRO;CLVS